Table 4. Examples of studies providing anatomically-specific information regarding the neural substrates of PPI, ca. 2001–2007.
Reference | Rat strain, sex | Brain regions | Manipulation | Effect on PPI | |
---|---|---|---|---|---|
I. NAC | |||||
Adults | |||||
Caceda et al. 2005 | LE, M | Virally mediated increase in NT1 receptor | Blocked AMP & DIZ-induced PPI deficits | ||
Culm et al. 2003 | SD, M | Infusion of PTX | Blocked QUIN-induced PPI deficit | ||
Culm et al. 2004 | SD, M | Infusion of Sp-cAMP | Blocked QUIN-induced PPI deficit | ||
Mohr et al. 2007 | Mice, C3H, F | Infusion of DIH or QUIN | ↑PPI after QUIN, but Ø PPI after DIH | ||
Nagel et al. 2003 | SD, M | Infusion of MSX-3 (A2 antagonist) | ↓PPI | ||
Pothuizen et al. 2005 | WI, M | Core, shell | Infusion of muscimol | Loss of PP intensity dependency after infusion into NAC core but not shell | |
Pothuizen et al. 2006 | WI, M | Core | NMDA-lesion of the NAC core | enhanced PPI disruption by DIZ but not APO | |
Powell et al. 2003 | LE, F | Intra-NAC 6-OHDA in SR & IR rats | blocked ↓ in PPI in IR rats | ||
Schwienbacher et al. 2002 | SD, M | + VTA | Infusion of DAergic, adenosinergic, or GABAergic compounds into NAC and/or VTA | ↑PPI after combined VTA PTX + NAC SCH23390 | |
Swerdlow et al. 2006d | SD, LE and F1 (SDxLE), M | + Striatum | Measured DA-stimulated [35S]GTPγS-binding in NAC, striatum | PPI-APO sensitivity: SD>F1>LE. [35S]GTPγS-binding in NAC, striatum: LE>F1>SD | |
II. HPC | |||||
Adults | |||||
Ellenbroek et al. 2002,b | WI, M | CA1 | Infusion of AMP, SKF81297 or QUIN | ↓PPI after AMP, SKF81297 or QUIN; AMP-induced PPI deficits blocked by intra-NAC SCH23390 but not sulpiride | |
Ma and Leung 2004 | LE, M | CA1 | Electrical kindling | ↓PPI (and ↓PA) | |
Finamore et al. 2001 | Rats | Infusion of KA or NMDA antagonists | ↓PPI with infusion of NMDA antagonists | ||
Fitting et al. 2006a | SD, M | Infusion of viral toxin TAT | ↑PPI (and ↓PA) | ||
Inada et al. 2003 | WI, M | Antisense NR1 knockdown | ↓PPI with knockdown 6, but not 14d pre-testing | ||
Neonates | |||||
Fitting et al. 2006c | SD, M, F | Neonatal infusion of viral toxin gp120 | ↓PPI (and ↑PA); + Vehicle: ↓PPI with increasing gp120 doses. + APO: ↑PPI with increasing gp120 doses | ||
Fitting et al. 2006b | SD, M, F | Neonatal TAT infusion | Males: ↓PPI at d 30 and 60, but not d 90 | ||
vHPC | |||||
Adults | |||||
Howland et al. 2004b | LE, M | + dHPC | Electrical stimulation VHPC vs. DHPC combined with NAC microdialysis | ↓PPI after VHPC but not DHPC stim.; ↑DA efflux: ipsi-but not contralateral NAC after unilateral stim. VHPC but not DHPC | |
Klamer et al. 2005b | SD, M | Microdialysis of the VHPC after systemic (or local) PCP | ↓PPI and ↑cAMP after PCP; blocked by NO-synthase inhibitor L-NAME | ||
Kusljic and van den Buuse 2004 | SD, M | + dHPC | 5,7-DHT lesion | ↓PPI for DHPC lesioned rats, and partially for VHPC lesioned rats | |
Zhang et al. 2002a | WI, M | + dHPC | Infusion of NMDA | ↓PPI after intra-VHPC but not-DHPC infusion | |
Swerdlow et al. 2004b | SD, M | + FX | Infusion of NMDA into the VHPC in rats with EL lesions of the FX | ↓PPI after NMDA infusion into VHPC, unaffected by FX lesion; IA lesion of the VHPC but not EL FX lesion enhanced ↓PPI by APO | |
Neonates | |||||
Laplante et al. 2005 | SD, M | IA-neonatal lesion | ↓PPI; blocked by biperiden | ||
Zhang et al. 2002b | WI, M | + dHPC | Muscimol or TTX infusion | ↓PPI, not blocked by HAL or CLO | |
Risterucci et al. 2005 | SD, M | IA-neonatal lesion | ↓PPI, ↓blood flow in NAC, BLA,VP, BNST, entorhinal–piriform and orbital CTX | ||
Adults | |||||
Caine et al. 2001 | LH, M | dSUB or vSUB | QA-lesions | ↓PPI after vSUB lesions. ↓PPI to AMP (not APO) after vSUB lesions. | |
III. PFC | |||||
Adults | |||||
de Jong and van den Buuse 2006 | SD, M | Infusion of SCH23390 | enhanced PPI deficits to APO but not DIZ | ||
Neonates | |||||
Grobin et al. 2006 | M, F | + MD | Neonatal elevation of allopregnanolone | ↓PPI in castrates before and after puberty (PD20 and 80), but Ø PPI during puberty (PD40 and 60) | |
Rajakumar et al. 2004 | SD, M | Neonatal infusion of antibody to the p75 neurtrophin receptor | ↓PPI at age 10 wks, but not 5 wks | ||
mPFC | |||||
Adults | |||||
Afonso et al. 2007 | SD, F | NMDA-lesion | ↓PPI | ||
Bast et al. 2001 | WI, M | Infusion of NMDA | ↓PPI, not blocked by HAL or CLO | ||
Day-Wilson et al. 2006 | LH, M | IR (associated with ↓mPFC volume) | ↓PPI | ||
Schwabe and Koch 2004 | WI, M | IA-lesion | lesion blocked DIZ-induced ↓PPI but not APO-induced ↓PPI | ||
Shoemaker et al. 2005 | SD, M | Infusion of SCH23390 into the mPFC; infusion of NMDA into the VHPC in rats with IA mPFC lesion | ↓PPI after infusion of SCH23390 in mPFC; mPFC lesions block ↓PPI after intra-VHPC NMDA infusion | ||
Swerdlow et al. 2006c | SD, M | + NAC | Systemic SCH23390, IA lesion of mPFC, 6-OHDA DA depletion of mPFC or NAC | ↓PPI after SCH23390, not blocked by either NAC DA depletion or mPFC lesion; ↓PPI after mPFC DA depletion | |
Neonates | |||||
Schneider and Koch 2005 | WI, M | IA-neonatal lesion | ↑PPI in juveniles; enhanced PPI deficits to APO in adults | ||
Schwabe et al. 2004 | WI, M | IA-neonatal lesion | ↑PPI after neonatal lesions; ↓PPI in both lesioned and intact rats after APO | ||
IV. eCTX | |||||
Adults | |||||
Goto et al. 2002 | WI, M | IA lesion | ↓PPI, partially blocked by HAL | ||
Goto et al. 2004 | WI, M | + NAC | eCTX lesion with IA, microdialysis of NAC | ↓PPI, ↑DA concentration in NAC | |
Uehara et al. 2007 | WI, M | + mPFC | eCTX lesion with QA, mPFC lidocaine infusion | ↓PPI after eCTX lesion or mPFC lidocaine | |
V. AMY | |||||
Neonatal | |||||
Daenen et al. 2003 | F1 of WI/ UWU, M | AMY (or vHPC) | Neonatal AMY or VHPC lesions with IA | ↓PPI in rats lesioned in the AMY or VHPC on d 7, but not on d 21 | |
BLA | |||||
Adults | |||||
Howland et al. 2007 | LE, M | + eCTX, + vHPC | Electrical kindling | ↓PPI shortly after kindling of BLA, but not of eCTX or VHPC | |
Kusljic and van den Buuse 2006 | SD, M | + CnA | 5,7-DHT lesion | ↓PPI with lesions of CnA but not BLA | |
Shoemaker et al. 2003 | SD, M | QA lesion of the BLA | ↓PPI, blocked by quetiapine | ||
Stevenson and Gratton 2004 | LE, M | + Striatum | Infusion of SCH23390 or raclopride | ↑PPI after intra-BLA SCH23390, ↓PPI after intra-BLA raclopride | |
VI. MD | |||||
Adults | |||||
Swerdlow et al. 2002c | SD, M | Infusion of QUIN or TTX | ↓PPI after TTX but not QUIN, not blocked by quetiapine | ||
VII. Habenula | |||||
Adults | |||||
Heldt andRessler 2006 | Mice, C57, M | Electrolytic lesion | Ø PPI in the absence of stress; but ↓PPI after stress in habenula lesioned rats; blocked by CLO | ||
VIII. mS | |||||
Adults | |||||
Ma and Leung 2007 | LE, M | + SUM | Infusion of muscimol | Muscimol into mS or SUM blocked ketamine-or DIZ-induced PPI deficits | |
Ma et al. 2004 | LE, M | Infusion of muscimol | Infusion of muscimol into mS blocked PCP-induced PPI deficits | ||
IX. NBM | |||||
Ballmaier et al. 2002 | SD, M | Immunolesion of cholinergic NBM neurons | ↓PPI, blocked by single or repeated admin. of rivastigmine | ||
X. IC | |||||
Adults | |||||
Silva et al. 2005 | LE, M | Electrical stimulation | ↓PPI | ||
Sandner et al. 2002 | SD, M | + PnC | Evoked potentials from IC or PnC | ↓PPI by ketamine and ↑evoked potentials | |
Yeomans et al. 2006 | WI, M | SC, + intercollicular nuc. or PPTg | Electrical PP and pulses via electrodes to the SC, IC, intercollicular nucleus, or PPTg | PPI after electrical PP to most SC sites. Longer PPI latencies for electrical PP to the SC than IC, intercollicular nuc. or PPTg | |
XI. PPTg | |||||
Adults | |||||
Diederich and Koch 2005 | WI, M | Infusion of muscimol | ↓PPI at intervals≥120 ms | ||
Takahashi et al. 2007 | Mice, ICR, M | + lGP, ssCTX | Infusion of phaclofen into the PPTg or lidocain into the lGP, c-fos labeling of brain regions after acoustic pulses or prepulses | ↓PPI after intra-PPTg phaclofen or intra-lGP lidocaine; ↑c-fos in lGP after prepulses; ↑c-fos in NAC shell, PnC, and ssCTX after pulses, blocked in NAC and PnC by prepulses | |
XII. LDTN, SN | |||||
Adults | |||||
Jones and Shannon 2004 | SD, M | IA-lesion of the LDTN or SN | ↓PPI after lesion of LDTN but not SN | ||
XIII. DRN or MRN | |||||
Adults | |||||
Kusljic et al. 2006 | SD, M | 5,7-DHT lesion | ↓PPI in MRN but not DRN lesioned rats, blocked by HAL or CLO | ||
Kusljic et al. 2003 | SD, M | 5,7-DHT lesion | ↓PPI at all PP intensities for MRN-lesioned rats and for some PP intensities for DRN lesioned rats | ||
XIV. Brainstem | |||||
Neonates | |||||
Shishkina et al. 2004 | WI, M | Neonatal infusion of antisense oligonucleotide complementary to the α2 adrenoceptor | ↓PPI at PD34, associated with ↑α2 adrenoceptors in HPC, AMY |
AMP Amphetamine, AMY amygdala, APO apomorphine, BG background, BLA basolateral amygdala, BNST bed nucleus of the stria terminalis, C57 C57BL/6J, CLO clozapine, CnA central nucleus of the amygdala, CPA N(6)-cyclopentanyladenosine, CTX cortex, d dorsal, 5,7-DHT 5,7 dihydroxytryptamine, DIH dihydrexidine, DIZ dizocilpine, DRN dorsal raphe nucleus, e entorhinal, EL electrolytic, F females, FX fornix, HAL haloperdidol, HPC hippocampus, IA ibotenic acid, IC inferior colliculus, IR isolation rearing, KA kainic acid, l lateral, LDTN laterodorsal tegmental nucleus, LE Long Evans, LH Lister Hooded, M males, m medial, MD dorsomedial thalamus, MET methamphetamine, MRN median raphe nucleus, NAC nucleus accumbens, NBM nucleus basalis of Meynert, NMDA N-methyl-d-aspartate, NO nitric oxide, OVX ovariectomized, NT neurotensin, 6-OHDA 6-hydroxydopamine, PD postnatal day, PA pulse alone trial, PCP phencyclidine, PFC prefrontal cortex, PnC nucleus reticularis pontis caudalis, PPI prepulse inhibition, PPTg pendunculopontine nucleus, PTX pertussis toxin, QA quinolinic acid, QUIN quinpirole, S septum, SD Sprague–Dawley, SC superior colliculus, SN substantia nigra, Sp-cAMP cyclic adenosine monophosphate analogue, SR socially reared, ss somatosensory, SUB subiculum, SUM supramamillary area, v ventral, VP ventral pallidum, VTA ventral tegmental area, WI Wistar, ↓decreased, ↑ increased, Ø unchanged